Antipeptide antibody responses following intranasal immunization: Effectiveness of mucosal adjuvants

Infection and Immunity

Volumn 68, Issue 9, 2000, Pages 4923-4929

  Olszewska, W ^a   Partidos, C D ^a   Steward, M W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; IMMUNOLOGICAL ADJUVANT; PEPTIDE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL TOXINS; DINUCLEOSIDE PHOSPHATES; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MEASLES VIRUS; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; VIRAL FUSION PROTEINS;

EID: 0033857494     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.9.4923-4929.2000     Document Type: Article

References (41)

1. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine
2. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
3. DNA-Based immunization for asthma
4. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing
5. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
6. + T-cell subsets in vivo
7. Gamma-interferon production by human low-density lymphocytes induced by T-cell mitogens
8. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells
9. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells
10. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin
11. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
12. Molecular basis of vaccination
13. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity
14. Lymphokine control of in vivo immunoglobulin isotype selection
15. Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit
16. Major histocompatibility complex allele-specific peptide libraries and identification of T-cell mimotopes
17. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity
18. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
19. A rapid method for the isolation of functional thymus-derived murine lymphocytes
20. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma
21. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming
22. Immuno-stimulatory effects of bacterial-derived plasmids depend on the nature of the antigen in intramuscular DNA inoculations
23. Immunostimulatory DNA: Sequence-dependent production of potentially harmful or useful cytokines
24. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses
25. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice
26. CpG DNA as mucosal adjuvant
27. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
28. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
29. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: The role of antibody affinity
30. The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide
31. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides
32. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis
33. An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity
34. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
35. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. 1. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines
36. + T cells
37. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells
38. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
39. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response
40. New strategies for using mucosal vaccination to achieve more effective immunization
41. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity